Skip to content
April 24, 2024

Equity.Guru

Investment information for the new generation

Search

Acute Myeloid Leukemia

Miraculous Microchip   Yes, you read that right. Earlier this week, German Aldana Zuniga got behind the wheel of an 850 horsepower NASCAR Cup race car. At first glance, this…
Medexus Pharmaceuticals Inc. (MDP.T) announced today that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to medac for treosulfan. “We have been actively working…
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however,…
Medexus Pharmaceuticals (MDP.T) today announced its financial results and provided a business update for the three-month period ended June 30, 2021.   “We continued to see pressure on IXINITY® ex-factory…
Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release.   Treosulfan will be sold in Canada using the brand name…